Researchers have developed a low-cost imaging system that can provide quantitative information about how deep within tissue a cancer cell resides. The system can help surgeons distinguish healthy tissue from tumors and could minimize health disparities in low-resource clinical centers. Source: Science Daily/Optica

NIBIB-funded researchers have developed an interlinked tissue chip system that can model four mature organs in their perspective environments simultaneously. These multi-organ tissue chips could represent a new way to evaluate diseases or drugs that affect multiple different tissues.

The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system.

NIBIB's Grace Peng provides an overview of the new NIH Bridge2AI program in an interview with Mimi Geerges. Source: Government Matters

New computed tomography (CT) technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional CT, according to a new study. Source: Science Daily/Radiological Society of North America

NIBIB Intramural Research Program labs collaborate with other NIH researchers on tackle engineering challenges.

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

The use of rapid Covid tests has soared this year with the spread of omicron and free shipments organized by the Biden Administration. But in August the US Food and Drug Administration cautioned that people who get a negative result should still repeat the test a couple days later. That communication has led to a lot of confusion. Source: Bloomberg

NIH announced it will provide funding to diagnostic test manufacturers for the development of the next generation of COVID-19 tests, with a focus on improved accessibility. Source: LabPulse